Mistral, the French AI lab, is working toward an initial public offering, co-founder and CEO Arthur Mensch said in an ...

Smithfield Foods is targeting a valuation of up to $10.73 billion in its U.S. initial public offering, the Farmland bacon ...

Smithfield Foods is targeting a valuation of up to $10.73 billion in its New York flotation, the biggest U.S. pork processor ...

French AI startup Mistral, dubbed Europe's OpenAI, plans an IPO, not a sale, as it expands globally with over €1 billion ...

Travel data provider Hopper Inc., one of Canada’s largest closely held technology companies, is eyeing a public listing that ...

India’s securities market regulator is considering steps to formalize trading in initial public offerings where bidding has ...

Thoma Bravo-owned cybersecurity company SailPoint on Friday revealed a narrower nine-month loss in its paperwork for a U.S.

Amagi, whose clients include NBC Universal, CBS, USA Today and Rakuten, is likely to file draft IPO papers after April. The ...

Smithfield Foods Inc. is offering Wall Street a seat at the table for potential growth in its packaged-meats business as the ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...